Kestra Advisory Services, LLC Cytosorbents Corp Transaction History
Kestra Advisory Services, LLC
- $17.2 Billion
- Q4 2024
A detailed history of Kestra Advisory Services, LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 55,000 shares of CTSO stock, worth $55,550. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,000
Previous 13,200
316.67%
Holding current value
$55,550
Previous $19,000
157.89%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CTSO
# of Institutions
57Shares Held
16.3MCall Options Held
15.4KPut Options Held
0-
Avenir Corp Washington, DC2.98MShares$3.01 Million0.45% of portfolio
-
Skylands Capital, LLC2.78MShares$2.81 Million0.38% of portfolio
-
Granahan Investment Management, LLC Waltham, MA2.09MShares$2.12 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.97 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.78MShares$1.8 Million0.0% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $44M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...